Skip to content
  • Thursday, May 8, 2025

New Economy World

The world economy is the economy of all humans in the world

Banner Add
  • Home
  • Blog
  • Finance News
  • Insurance
  • Investing
  • Construction
  • Property
  • Stock
  • Tech
  • Venture Capital
  • Home
  • Stock
  • Ellington Financial Q1 2025 slides: $0.35 EPS, strategic portfolio shift continues
Stock

Ellington Financial Q1 2025 slides: $0.35 EPS, strategic portfolio shift continues

08/05/2025
admin


Ellington Financial Q1 2025 slides: $0.35 EPS, strategic portfolio shift continues#Ellington #Financial #slides #EPS #strategic #portfolio #shift #continues

Tags: Continues, Ellington, EPS, financial, portfolio, shift, slides, Strategic

Post navigation

Nutanix escapes the datacentre with Cloud Native AOS
American Financial Group: Poised For Special Dividends Despite A Q1 Miss

Finance and Economics

Recent Posts

Tech

Starlink’s launch in India now a matter of when, not if

08/05/2025
admin
Stock

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer

08/05/2025
admin
Finance News

ACM Research, Inc. 2025 Q1 – Results – Earnings Call Presentation

08/05/2025
admin
Tech

China’s Geely moves to take EV startup Zeekr private amid trade war with US

08/05/2025
admin
Stock

Bitcoin tops $100,000 on trade deal optimism

08/05/2025
admin
Finance News

Krispy Kreme: Avoid These Stale Doughnuts

08/05/2025
admin
Tech

Google rolls out AI tools to protect Chrome users against scams

08/05/2025
admin

Recent Posts

Tech

Starlink’s launch in India now a matter of when, not if

08/05/2025
admin
Stock

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer

08/05/2025
admin

Recent Posts

Tech

Starlink’s launch in India now a matter of when, not if

08/05/2025
admin
Stock

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer

08/05/2025
admin

Recent Posts

Tech

Starlink’s launch in India now a matter of when, not if

08/05/2025
admin
Stock

FDA Approves the AVMAPKI™ FAKZYNJA™ Combination Therapy as the First-Ever Treatment for Adult Patients with KRAS-mutated Recurrent Low-Grade Serous Ovarian Cancer

08/05/2025
admin
New Economy World News